Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...
ScreenRant on MSN5d
10 Things Marvel Fans Should Miss Most About The MCU's Phase 1
The MCU has grown considerably since its earliest stages, but there are many aspects of Phase 1 that Marvel fans should ...